CVE:MPH

Medicure Inc. (MPH.V) Stock Forecast, Price & News

C$1.65

+0.26 (+18.71 %)

(As of 01/22/2021 03:53 PM ET)

Add

Compare

Today's Range

C$1.41

Now: C$1.65▼

C$2.01

50-Day Range

C$0.02

MA: C$1.12▼

C$1.51

52-Week Range

C$0.70

Now: C$1.65▼

C$3.80

Volume48,280 shs

Average Volume34,442 shs

Market CapitalizationC$17.24 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Medicure Inc., a pharmaceutical company, engages in the research, development, and commercialization of therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that provides measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Overall MarketRank^™

0.73 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Medicure Inc. (MPH.V).

3.0 Community Rank

Outperform Votes
Medicure Inc. (MPH.V) has received 111 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Medicure Inc. (MPH.V) has received 75 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Medicure Inc. (MPH.V) has received 59.68% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Medicure Inc. (MPH.V) and other stocks. Vote “Outperform” if you believe MPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Medicure Inc. (MPH.V) does not currently pay a dividend.
Dividend Growth
Medicure Inc. (MPH.V) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Medicure Inc. (MPH.V) insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Medicure Inc. (MPH.V) is -1.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Medicure Inc. (MPH.V) is -1.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Medicure Inc. (MPH.V) has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange CVE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolCVE:MPH

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.medicure.com

Phone+1-204-4877412

EmployeesN/A

Debt

Debt-to-Equity Ratio3.87

Current Ratio3.37

Quick Ratio2.38

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesC$12.71 million

Price / Sales1.36

Cash FlowC$1.24 per share

Price / Cash Flow1.33

Book ValueC$2.30 per share

Price / Book0.72

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares10,451,000

Market CapC$17.24 million

Next Earnings Date4/21/2021 (Estimated)

OptionableNot Optionable

C$1.65

+0.26 (+18.71 %)

(As of 01/22/2021 03:53 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive MPH News and Ratings via Email

Sign-up to receive the latest news and ratings for MPH and its competitors with MarketBeat's FREE daily newsletter.

Medicure Inc. (MPH.V) (CVE:MPH) Frequently Asked Questions

How has Medicure Inc. (MPH.V)'s stock been impacted by COVID-19?

Medicure Inc. (MPH.V)'s stock was trading at C$2.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MPH shares have decreased by 17.5% and is now trading at C$1.65.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Medicure Inc. (MPH.V)?

Wall Street analysts have given Medicure Inc. (MPH.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medicure Inc. (MPH.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Medicure Inc. (MPH.V)'s next earnings date?

Medicure Inc. (MPH.V) is scheduled to release its next quarterly earnings announcement on Wednesday, April 21st 2021.
View our earnings forecast for Medicure Inc. (MPH.V).

How were Medicure Inc. (MPH.V)'s earnings last quarter?

Medicure Inc. (MPH.V) (CVE:MPH) posted its quarterly earnings data on Wednesday, November, 11th. The company reported ($0.10) earnings per share for the quarter. The business earned $3.55 million during the quarter.
View Medicure Inc. (MPH.V)'s earnings history.

Who are some of Medicure Inc. (MPH.V)'s key competitors?

Some companies that are related to Medicure Inc. (MPH.V) include IXICO plc (IXI.L) (IXI), Rua Life Sciences Plc (RUA.L) (RUA), Covalon Technologies Ltd. (COV.V) (COV), Hemogenyx Pharmaceuticals Plc (HEMO.L) (HEMO), Tissue Regenix Group plc (TRX.L) (TRX), Emerald Health Therapeutics, Inc. (EMH.V) (EMH), Fusion Antibodies plc (FAB.L) (FAB), ProMIS Neurosciences, Inc. (PMN.TO) (PMN), IntelGenx Technologies Corp. (IGX.V) (IGX), ImmuPharma plc (IMM.L) (IMM), Collagen Solutions plc (COS.L) (COS), AorTech International (AOR), Quest PharmaTech Inc. (QPT.V) (QPT), Ceapro Inc. (CZO.V) (CZO) and Biopharmx (BPMX).
View all of MPH's competitors.

What other stocks do shareholders of Medicure Inc. (MPH.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicure Inc. (MPH.V) investors own include Dollarama Inc. (DOL.TO) (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), ProMetic Life Sciences (PLI), Hudbay Minerals Inc. (HBM.TO) (HBM), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Detour Gold (DGC), Sinovac Biotech (SVA) and Viking Therapeutics (VKTX).

Who are Medicure Inc. (MPH.V)'s key executives?

Medicure Inc. (MPH.V)'s management team includes the following people:

Dr. Albert David Friesen, Founder, CEO & Chairman of the board (Age 74, Pay $346.5k)
Dr. Neil Owens Ph.D., Pres & COO
Mr. James F. Kinley CPA, C.A., CFO & Sec. (Age 43, Pay $185k)
Ms. Jamie Gowryluk, VP of Commercial Operations
Dr. Reuben Saba Ph.D., VP of Scientific & Medical Affairs

What is Medicure Inc. (MPH.V)'s stock symbol?

Medicure Inc. (MPH.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."

How do I buy shares of Medicure Inc. (MPH.V)?

Shares of MPH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Medicure Inc. (MPH.V)'s stock price today?

One share of MPH stock can currently be purchased for approximately C$1.65.

How big of a company is Medicure Inc. (MPH.V)?

Medicure Inc. (MPH.V) has a market capitalization of C$17.24 million and generates C$12.71 million in revenue each year.

What is Medicure Inc. (MPH.V)'s official website?

The official website for Medicure Inc. (MPH.V) is www.medicure.com.

How can I contact Medicure Inc. (MPH.V)?

Medicure Inc. (MPH.V)'s mailing address is 1250 Waverley St Suite 2, WINNIPEG, MB R3T 6C6, Canada. The company can be reached via phone at +1-204-4877412.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Medicure Inc. (MPH.V) Stock Forecast, Price & News

Adding

Adding

Adding Medicure Inc. (MPH.V)

MarketRank™

Overall MarketRank™